Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a New Method for Detecting Cancer Pathologies by Measuring the Activity of Different Glycosidases in Plasma in Patients With Localized Cancer - Pilot Study: B-GLUCANCER2

NCT07236177 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT07236177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07236177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a New Method for Detecting Cancer Pathologies by Measuring the Activity of Different Glycosidases in Plasma in Patients With Localized Cancer - Pilot Study: B-GLUCANCER2
Lead sponsor
Poitiers University Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
February 3, 2026
Completion date
March 3, 2028
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, glycosidase activity, pancreatic cancer, probes, pulmonary cancer, tumor markers, biological, volatile organic compound